| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Platelet-activating factor receptor |
|---|
| Ligand | BDBM50011624 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_56498 |
|---|
| IC50 | 5±n/a nM |
|---|
| Citation |  Walser, A; Flynn, T; Mason, C; Crowley, H; Maresca, C; Yaremko, B; O'Donnell, M Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor. J Med Chem34:1209-21 (1991) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Platelet-activating factor receptor |
|---|
| Name: | Platelet-activating factor receptor |
|---|
| Synonyms: | PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 39219.60 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | PAF Platelet activating factor PTAFR HUMAN::P25105 |
|---|
| Residue: | 342 |
|---|
| Sequence: | MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLT
MADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVT
RPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKG
SVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAV
FIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKF
RKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
|
|
|
|---|
| BDBM50011624 |
|---|
| n/a |
|---|
| Name | BDBM50011624 |
|---|
| Synonyms: | 2-(3-Benzoimidazol-1-yl-prop-1-ynyl)-4-(2-chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene | CHEMBL277029 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C25H17ClN6S |
|---|
| Mol. Mass. | 468.961 |
|---|
| SMILES | Cc1nnc2CN=C(c3cc(sc3-n12)C#CCn1cnc2ccccc12)c1ccccc1Cl |c:6| |
|---|
| Structure | 
|
|---|
Search and Browse
